Gastroenterology Services, Ltd., 3825 Highland Ave, Suite 203, Downers Grove, IL, 60515, USA.
BMC Gastroenterol. 2023 May 11;23(1):146. doi: 10.1186/s12876-023-02663-0.
Inadequate bowel preparation for colonoscopy remains an issue resulting in lower adenoma detection rates and increased cost. We assessed the efficacy, safety and tolerability of high-dose bowel preparations in subjects who previously had an inadequate colonoscopy preparation.
We performed a multi-step prospective trial of high-dose bowel preparations with subjects assigned to the dose higher than their previous inadequate preparation. Step 1: 1.5 times the standard-dose of polyethylene glycol 3350 (PEG, 459 g) and Gatorade; and Step 2: 2.0 times the standard-dose of PEG (612 g) and Gatorade, both were given as extended split-dose preparations. 69 outpatients consumed their preparation before a morning colonoscopy. The primary endpoint was colon cleanliness assessed by the Chicago bowel preparation scale (BPS). Safety was assessed by comparing a baseline basic metabolic panel (BMP) to a post-cleansing BMP. Patients with no history of inadequate colon cleansing who consumed standard doses of PEG (306 g to 357 g) and Gatorade were used as a comparison group. Tolerability of the bowel preparation was assessed using a subject-questionnaire.
When compared to controls consuming standard-dose bowel preparations, subjects consuming high-dose preparations had no statistically significant difference in colon cleanliness as measured by the modified or total Chicago BPS scores or differences in tolerability. Baseline and post-cleaning BMPs were not significantly different other than the BUN falling (p < 0.0001) after the preparation.
The multi-step high-dose bowel cleansing protocol proved highly efficacious, safe and well tolerated in subjects who previously had an inadequate colonoscopy preparation.
ClinicalTrials.gov NCT02661750.
结肠镜检查前肠道准备不足仍然是一个问题,导致腺瘤检出率降低和成本增加。我们评估了高剂量肠道准备在先前肠道准备不足的患者中的疗效、安全性和耐受性。
我们对高剂量肠道准备进行了多步骤前瞻性试验,将患者分配到高于其先前不足准备的剂量。第 1 步:聚乙二醇 3350(PEG,459g)和佳得乐的标准剂量的 1.5 倍;第 2 步:PEG(612g)和佳得乐的标准剂量的 2 倍,均作为延长的分剂量制剂给予。69 名门诊患者在上午结肠镜检查前服用准备药物。主要终点是通过芝加哥肠道准备量表(BPS)评估的结肠清洁度。安全性通过比较基线基本代谢小组(BMP)与清洁后 BMP 来评估。将使用曾服用标准剂量 PEG(306g 至 357g)和佳得乐且无肠道清洁不足病史的患者作为对照组。使用患者问卷评估肠道准备的耐受性。
与服用标准剂量肠道准备的对照组相比,服用高剂量肠道准备的患者在改良或总芝加哥 BPS 评分测量的结肠清洁度方面无统计学差异,或在耐受性方面无差异。除准备后 BUN 下降(p<0.0001)外,基线和清洁后 BMP 无显著差异。
多步骤高剂量肠道清洁方案在先前肠道准备不足的患者中证明具有高度疗效、安全性和耐受性。
ClinicalTrials.gov NCT02661750。